{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:55:53Z","timestamp":1791359753516,"version":"4.3.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T00:00:00Z","timestamp":1294099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10620-010-1494-9","type":"journal-article","created":{"date-parts":[[2011,1,3]],"date-time":"2011-01-03T07:02:44Z","timestamp":1294038164000},"page":"1601-1611","source":"Crossref","is-referenced-by-count":85,"title":["Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"56","author":[{"given":"Anastassios C.","family":"Manolakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas N.","family":"Kapsoritakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet K.","family":"Tiaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros P.","family":"Potamianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,4]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","volume":"19","author":"BW Moore","year":"1965","unstructured":"Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commmun. 1965;19:739\u2013744.","journal-title":"Biochem Biophys Res Commmun"},{"key":"1494_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20060195","volume":"396","author":"L Santamaria-Kisiel","year":"2006","unstructured":"Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J. 2006;396:201\u2013214.","journal-title":"Biochem J"},{"key":"1494_CR3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jemt.10296","volume":"60","author":"R Donato","year":"2003","unstructured":"Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech. 2003;60:540\u2013551.","journal-title":"Microsc Res Tech"},{"key":"1494_CR4","doi-asserted-by":"crossref","unstructured":"Foell D, Frosch M, Sorg C, et al. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation. Clin Chim Acta. 2004;344:3751.","DOI":"10.1016\/j.cccn.2004.02.023"},{"key":"1494_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","volume":"81","author":"D Foell","year":"2007","unstructured":"Foell D, Wittkowski H, Vogl T, et al. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81:28\u201337.","journal-title":"J Leukoc Biol"},{"key":"1494_CR6","doi-asserted-by":"crossref","first-page":"31317","DOI":"10.1074\/jbc.M703951200","volume":"282","author":"E Leclerc","year":"2007","unstructured":"Leclerc E, Fritz G, Weibel M, et al. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem. 2007;282:31317\u201331331.","journal-title":"J Biol Chem"},{"key":"1494_CR7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejso.2007.04.009","volume":"34","author":"I Salama","year":"2008","unstructured":"Salama I, Malone PS, Mihaimeed F, et al. A review of the S100 proteins in cancer. Eur J Surg Oncol. 2008;34:357\u2013364.","journal-title":"Eur J Surg Oncol"},{"key":"1494_CR8","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/jnr.21211","volume":"85","author":"J Sen","year":"2007","unstructured":"Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res. 2007;85:1373\u20131380.","journal-title":"J Neurosci Res"},{"key":"1494_CR9","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/CIRCULATIONAHA.106.671701","volume":"115","author":"ST Pleger","year":"2007","unstructured":"Pleger ST, Most P, Boucher M, et al. Stable myocardial-specific AAV6\u2013S100A1 gene therapy results in chronic functional heart failure rescue. Circulation. 2007;115:2506\u20132515.","journal-title":"Circulation"},{"key":"1494_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","volume":"123","author":"RL Eckert","year":"2004","unstructured":"Eckert RL, Broome AM, Ruse M, et al. S100 proteins in the epidermis. J Invest Dermatol. 2004;123:23\u201333.","journal-title":"J Invest Dermatol"},{"key":"1494_CR11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2006\/509476","volume":"22","author":"G Giovannoni","year":"2006","unstructured":"Giovannoni G. Multiple sclerosis cerebrospinal fluid biomarkers. Dis Markers. 2006;22:187\u2013196.","journal-title":"Dis Markers"},{"key":"1494_CR12","first-page":"3051","volume":"27","author":"R Yao","year":"2007","unstructured":"Yao R, Lopez-Beltran A, Maclennan GT, Montironi R, Eble JN, Cheng L. Expression of S100 protein family members in the pathogenesis of bladder tumors. Anticancer Res. 2007;27:3051\u20133058.","journal-title":"Anticancer Res"},{"key":"1494_CR13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.0305-1846.2003.00525.x","volume":"30","author":"S Hancq","year":"2004","unstructured":"Hancq S, Salmon I, Brotchi J, et al. S100A5: a marker of recurrence in WHO grade I meningiomas. Neuropathol Appl Neurobiol. 2004;30:178\u2013187.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1494_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejca.2007.10.017","volume":"44","author":"A Pierce","year":"2008","unstructured":"Pierce A, Barron N, Linehan R, et al. Identification of a novel, functional role for S100A13 in invasive lung cancer cell lines. Eur J Cancer. 2008;44:151\u2013159.","journal-title":"Eur J Cancer"},{"key":"1494_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-006-9189-y","volume":"80","author":"M Landriscina","year":"2006","unstructured":"Landriscina M, Schinzari G, Di Leonardo G, et al. S100A13, a new marker of angiogenesis in human astrocytic gliomas. J Neurooncol. 2006;80:251\u2013259.","journal-title":"J Neurooncol"},{"key":"1494_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(03)00243-2","volume":"335","author":"F Michetti","year":"2003","unstructured":"Michetti F, Gazzolo D. S100B testing in pregnancy. Clin Chim Acta. 2003;335:1\u20137.","journal-title":"Clin Chim Acta"},{"key":"1494_CR17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2007.06.009","volume":"133","author":"G Esposito","year":"2007","unstructured":"Esposito G, Cirillo C, Sarnelli G, et al. Enteric glial-derived S100B protein stimulates nitric oxide production in celiac disease. Gastroenterology. 2007;133:918\u2013925.","journal-title":"Gastroenterology"},{"key":"1494_CR18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/hmg\/10.5.445","volume":"10","author":"IC Lawrance","year":"2001","unstructured":"Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn\u2019s disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet. 2001;10:445\u2013456.","journal-title":"Hum Mol Genet"},{"key":"1494_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","volume":"24","author":"J Roth","year":"2003","unstructured":"Roth J, Vogl T, Sorg C, et al. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 2003;24:155\u2013158.","journal-title":"Trends Immunol"},{"key":"1494_CR20","doi-asserted-by":"crossref","first-page":"25291","DOI":"10.1074\/jbc.274.36.25291","volume":"274","author":"T Vogl","year":"1999","unstructured":"Vogl T, Propper C, Hartmann M, et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem. 1999;274:25291\u201325296.","journal-title":"J Biol Chem"},{"key":"1494_CR21","first-page":"6823","volume":"62","author":"W El-Rifai","year":"2002","unstructured":"El-Rifai W, Moskaluk CA, Abdrabbo MK, et al. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 2002;62:6823\u20136826.","journal-title":"Cancer Res"},{"key":"1494_CR22","doi-asserted-by":"crossref","unstructured":"Liu J, Li X, Dong GL, et al. In silico analysis and verification of S100 gene expression in gastric cancer. BMC Cancer. 2008;8:261.","DOI":"10.1186\/1471-2407-8-261"},{"key":"1494_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1600-0714.2008.00683.x","volume":"37","author":"D Sapkota","year":"2008","unstructured":"Sapkota D, Bruland O, B\u00f8e OE, et al. Expression profile of the S100 gene family members in oral squamous cell carcinomas. J Oral Pathol Med. 2008;37:607\u2013615.","journal-title":"J Oral Pathol Med"},{"key":"1494_CR24","first-page":"480","volume":"130","author":"J Ji","year":"2004","unstructured":"Ji J, Zhao L, Wang X, et al. Differential expression of S100 gene family in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2004;130:480\u2013486.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1494_CR25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00268-004-7843-0","volume":"29","author":"JA Rodriguez","year":"2005","unstructured":"Rodriguez JA, Li M, Yao Q, et al. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications. World J Surg. 2005;29:297\u2013305.","journal-title":"World J Surg"},{"key":"1494_CR26","first-page":"247","volume":"37","author":"C Capella","year":"1990","unstructured":"Capella C, Riva C, Rindi G, et al. Endocrine tumors of the duodenum and upper jejunum. A study of 33 cases with clinico-pathological characteristics and hormone content. Hepatogastroenterology. 1990;37:247\u2013252.","journal-title":"Hepatogastroenterology"},{"key":"1494_CR27","first-page":"233","volume":"35","author":"MD Srivastava","year":"2004","unstructured":"Srivastava MD, Kulaylat MN. Gene expression profiles of late colonic Crohn\u2019s disease. J Med. 2004;35:233\u2013255.","journal-title":"J Med"},{"key":"1494_CR28","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0016-5085(97)70030-1","volume":"112","author":"J Rugtveit","year":"1997","unstructured":"Rugtveit J, Nilsen EM, Bakka A, et al. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology. 1997;112:1493\u20131505.","journal-title":"Gastroenterology"},{"key":"1494_CR29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2559.1996.d01-416.x","volume":"28","author":"P Sarsfield","year":"1996","unstructured":"Sarsfield P, Jones DB, Wright DH. Accessory cells in Crohn\u2019s disease of the terminal ileum. Histopathology. 1996;28:213\u2013219.","journal-title":"Histopathology"},{"key":"1494_CR30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0046-8177(97)90127-1","volume":"28","author":"T Waraich","year":"1997","unstructured":"Waraich T, Sarsfield P, Wright DH. The accessory cell populations in ulcerative colitis: a comparison between the colon and appendix in colitis and acute appendicitis. Hum Pathol. 1997;28:297\u2013303.","journal-title":"Hum Pathol"},{"key":"1494_CR31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1369\/jhc.7A7308.2007","volume":"56","author":"MI Verstege","year":"2008","unstructured":"Verstege MI, ten Kate FJ, Reinartz SM, et al. Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn\u2019s disease. J Histochem Cytochem. 2008;56:233\u2013241.","journal-title":"J Histochem Cytochem"},{"key":"1494_CR32","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0016-5085(92)90762-N","volume":"102","author":"Y Kubota","year":"1992","unstructured":"Kubota Y, Petras RE, Ottaway CA, et al. Colonic vasoactive intestinal peptide nerves in inflammatory bowel disease. Gastroenterology. 1992;102:1242\u20131251.","journal-title":"Gastroenterology"},{"key":"1494_CR33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gut.52.6.847","volume":"52","author":"D Foell","year":"2003","unstructured":"Foell D, Kucharzik T, Kraft M, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003;52:847\u2013853.","journal-title":"Gut"},{"key":"1494_CR34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, Yang Z, Messina I, et al. Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42:1321\u20131331.","journal-title":"Scand J Gastroenterol"},{"key":"1494_CR35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/gut.37.3.367","volume":"37","author":"J Rugtveit","year":"1995","unstructured":"Rugtveit J, Haraldsen G, Hogasen AK, et al. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14\u00a0+\u00a0L1\u00a0+\u00a0monocyte derived cells. Gut. 1995;37:367\u2013373.","journal-title":"Gut"},{"key":"1494_CR36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000201267","volume":"56","author":"N L\u00fcgering","year":"1995","unstructured":"L\u00fcgering N, Stoll R, Kucharzik T, et al. Immunohistochemical distribution and serum levels of the Ca(2\u00a0+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8\/14 in Crohn\u2019s disease. Digestion. 1995;56:406\u2013414.","journal-title":"Digestion"},{"issue":"Suppl 2","key":"1494_CR37","first-page":"A138","volume":"57","author":"AN Kapsoritakis","year":"2008","unstructured":"Kapsoritakis AN, Georgoulias PA, Manolakis AC, et al. Serum S100A12, a marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut. 2008;57:A138.","journal-title":"Gut"},{"key":"1494_CR38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.ibd.0000227626.72271.91","volume":"12","author":"NS Jong de","year":"2006","unstructured":"de Jong NS, Leach ST, Day AS. Fecal S100A12: a novel noninvasive marker in children with Crohn\u2019s disease. Inflamm Bowel Dis. 2006;12:566\u2013572.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR39","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/gut.2006.113431","volume":"56","author":"T Kaiser","year":"2007","unstructured":"Kaiser T, Langhorst J, Wittkowski H, et al. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut. 2007;56:1706\u20131713.","journal-title":"Gut"},{"key":"1494_CR40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ibd.20336","volume":"14","author":"MA Sidler","year":"2008","unstructured":"Sidler MA, Leach ST, Day AS. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis. 2008;14:359\u2013366.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/path.2394","volume":"216","author":"D Foell","year":"2008","unstructured":"Foell D, Wittkowski H, Ren Z, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008;216:183\u2013192.","journal-title":"J Pathol"},{"key":"1494_CR42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.cgh.2008.04.021","volume":"6","author":"J Karl","year":"2008","unstructured":"Karl J, Wild N, Tacke M, et al. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers. Clin Gastroenterol Hepatol. 2008;6:1122\u20131128.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1494_CR43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MPG.0b013e31810e75a9","volume":"45","author":"UL Fagerberg","year":"2007","unstructured":"Fagerberg UL, L\u00f6\u00f6f L, Lindholm J, et al. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;45:414\u2013420.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1494_CR44","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1572-0241.2007.01126.x","volume":"102","author":"AC Roon von","year":"2007","unstructured":"von Roon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007;102:803\u2013813.","journal-title":"Am J Gastroenterol"},{"key":"1494_CR45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MPG.0b013e31816533d3","volume":"48","author":"M Joishy","year":"2009","unstructured":"Joishy M, Davies I, Ahmed M, et al. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:48\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1494_CR46","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00384-006-0159-9","volume":"22","author":"R D\u2019Inc\u00e0","year":"2007","unstructured":"D\u2019Inc\u00e0 R, Dal Pont E, Di Leo V, et al. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis. 2007;22:429\u2013437.","journal-title":"Int J Colorectal Dis"},{"key":"1494_CR47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1572-0241.2007.01556.x","volume":"103","author":"J Langhorst","year":"2008","unstructured":"Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162\u2013169.","journal-title":"Am J Gastroenterol"},{"key":"1494_CR48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2036.2004.02128.x","volume":"20","author":"S Dolwani","year":"2004","unstructured":"Dolwani S, Metzner M, Wassell JJ, et al. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther. 2004;20:615\u2013621.","journal-title":"Aliment Pharmacol Ther"},{"key":"1494_CR49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ibd.20275","volume":"14","author":"AM Schoepfer","year":"2008","unstructured":"Schoepfer AM, Trummler M, Seeholzer P, et al. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis. 2008;14:32\u201339.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR50","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1515\/CCLM.2008.246","volume":"46","author":"CM Otten","year":"2008","unstructured":"Otten CM, Kok L, Witteman BJ, et al. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med. 2008;46:1275\u20131280.","journal-title":"Clin Chem Lab Med"},{"key":"1494_CR51","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1111\/j.1572-0241.2000.03194.x","volume":"95","author":"PJ Limburg","year":"2000","unstructured":"Limburg PJ, Ahlquist DA, Sanborn WJ, et al. Faecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol. 2000;95:2831\u20132837.","journal-title":"Am J Gastroenterol"},{"key":"1494_CR52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1373\/49.6.861","volume":"49","author":"A Caroccio","year":"2003","unstructured":"Caroccio A, Iacono G, Cottone M, et al. Diagnostic accuracy of faecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem. 2003;49:861\u2013867.","journal-title":"Clin Chem"},{"key":"1494_CR53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S1590-8658(03)00381-5","volume":"35","author":"F Costa","year":"2003","unstructured":"Costa F, Mumolo MG, Bellini M, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liv Dis. 2003;35:642\u2013647.","journal-title":"Dig Liv Dis"},{"key":"1494_CR54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1155\/2008\/308942","volume":"22","author":"ST Leach","year":"2008","unstructured":"Leach ST, Mitchell HM, Geczy CL, et al. S100 calgranulin proteins S100A8, S100A9 and S100A12 are expressed in the inflamed gastric mucosa of Helicobacter pylori-infected children. Can J Gastroenterol. 2008;22:461\u2013464.","journal-title":"Can J Gastroenterol"},{"key":"1494_CR55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00384-008-0595-9","volume":"24","author":"A Tursi","year":"2009","unstructured":"Tursi A, Brandimarte G, Elisei W, et al. Faecal calprotectin in colonic diverticular disease: a case-control study. Int J Colorectal Dis. 2009;24:49\u201355.","journal-title":"Int J Colorectal Dis"},{"key":"1494_CR56","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1080\/08035250500254639","volume":"94","author":"A Bremner","year":"2005","unstructured":"Bremner A, Roked S, Robinson R, et al. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr. 2005;94:1855\u20131858.","journal-title":"Acta Paediatr"},{"key":"1494_CR57","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/gut.49.3.402","volume":"49","author":"J Tibble","year":"2001","unstructured":"Tibble J, Sigthorsson G, Foster R, et al. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Gut. 2001;49:402\u2013408.","journal-title":"Gut"},{"key":"1494_CR58","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/gut.2004.039032","volume":"53","author":"G Hoff","year":"2004","unstructured":"Hoff G, Grotmol T, Thiis-Evensen E, et al. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Gut. 2004;53:1329\u20131333.","journal-title":"Gut"},{"key":"1494_CR59","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1365-2036.2008.03663.x","volume":"27","author":"L Wedlake","year":"2008","unstructured":"Wedlake L, McGough C, Hackett C, et al. Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa? Aliment Pharmacol Ther. 2008;27:980\u2013987.","journal-title":"Aliment Pharmacol Ther"},{"key":"1494_CR60","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/00365520701320505","volume":"42","author":"CA Reinders","year":"2007","unstructured":"Reinders CA, Jonkers D, Janson EA, et al. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scand J Gastroenterol. 2007;42:1151\u20131157.","journal-title":"Scand J Gastroenterol"},{"key":"1494_CR61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1055-9965.EPI-03-0160","volume":"13","author":"A Poullis","year":"2004","unstructured":"Poullis A, Foster R, Shetty A, et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:279\u2013284.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1494_CR62","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/01.MIB.0000187980.08686.18","volume":"11","author":"J Langhorst","year":"2005","unstructured":"Langhorst J, Elsenbruch S, Mueller T, et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis. 2005;11:1085\u20131091.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ibd.20312","volume":"14","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, Kolho KL, et al. Crohn\u2019s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn\u2019s disease activity index and endoscopic findings. Inflamm Bowel Dis. 2008;14:40\u201346.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR64","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ibd.20490","volume":"14","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, K\u00e4rkk\u00e4inen P, et al. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn\u2019s disease. Inflamm Bowel Dis. 2008;14:1392\u20131398.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR65","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2008.03835.x","volume":"28","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, K\u00e4rkk\u00e4inen P, Savilahti E, et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn\u2019s disease and histological findings. Aliment Pharmacol Ther. 2008;28:1221\u20131229.","journal-title":"Aliment Pharmacol Ther"},{"key":"1494_CR66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.dld.2008.01.017","volume":"40","author":"RB Canani","year":"2008","unstructured":"Canani RB, Terrin G, Rapacciuolo L, et al. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis. 2008;40:547\u2013553.","journal-title":"Dig Liver Dis"},{"key":"1494_CR67","doi-asserted-by":"crossref","unstructured":"Vieira A, Fang CB, Rolim EG, et al. Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes. BMC Res Notes. 2009;2:221.","DOI":"10.1186\/1756-0500-2-221"},{"key":"1494_CR68","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ibd.20986","volume":"15","author":"AM Schoepfer","year":"2009","unstructured":"Schoepfer AM, Beglinger C, Straumann A, et al. Ulcerative colitis: Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leucocytes. Inflamm Bowel Dis. 2009;15:1851\u20131858.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","volume":"105","author":"AM Schoepfer","year":"2010","unstructured":"Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn\u2019s disease (SES-CD) than CRP, blood leucocytes, and the CDAI. Am J Gastroenterol. 2010;105:162\u2013169.","journal-title":"Am J Gastroenterol"},{"key":"1494_CR70","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1080\/00365520500419623","volume":"41","author":"KL Kolho","year":"2006","unstructured":"Kolho KL, Raivio T, Lindahl H, et al. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol. 2006;41:720\u2013725.","journal-title":"Scand J Gastroenterol"},{"key":"1494_CR71","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s10350-007-0225-6","volume":"50","author":"M Scarpa","year":"2007","unstructured":"Scarpa M, D\u2019Inc\u00e0 R, Basso D, et al. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn\u2019s disease. Dis Colon Rectum. 2007;50:861\u2013869.","journal-title":"Dis Colon Rectum"},{"key":"1494_CR72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119:15\u201322.","journal-title":"Gastroenterology"},{"key":"1494_CR73","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/gut.2004.043406","volume":"54","author":"F Costa","year":"2005","unstructured":"Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn\u2019s disease. Gut. 2005;54:364\u2013368.","journal-title":"Gut"},{"key":"1494_CR74","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1572-0241.2008.01870.x","volume":"103","author":"R D\u2019Inc\u00e0","year":"2008","unstructured":"D\u2019Inc\u00e0 R, Dal Pont E, Di Leo V, et al. Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol. 2008;103:2007\u20132014.","journal-title":"Am J Gastroenterol"},{"key":"1494_CR75","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/ibd.20933","volume":"15","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Bermejo F, Perez-Calle JL, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis. 2009;15:1190\u20131198.","journal-title":"Inflamm Bowel Dis"},{"key":"1494_CR76","first-page":"17","volume":"10","author":"A Orlando","year":"2006","unstructured":"Orlando A, Modesto I, Castiglione F, et al. The role of calprotectin in predicting endoscopic post-surgical recurrence in asymptomatic Crohn\u2019s disease: a comparison with ultrasound. Eur Rev Med Pharmacol Sci. 2006;10:17\u201322.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1494_CR77","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bjs.6593","volume":"96","author":"CA Lamb","year":"2009","unstructured":"Lamb CA, Mohiuddin MK, Gicquel J, et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn\u2019s disease. Br J Surg. 2009;96:663\u2013674.","journal-title":"Br J Surg"},{"key":"1494_CR78","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF02236986","volume":"43","author":"P Thomas","year":"2000","unstructured":"Thomas P, Rihani H, R\u00f8seth A, et al. Assessment of ileal pouch inflammation by single-stool calprotectin assay. Dis Colon Rectum. 2000;43:214\u2013220.","journal-title":"Dis Colon Rectum"},{"key":"1494_CR79","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MEG.0b013e3282f1c9a7","volume":"20","author":"MW Johnson","year":"2008","unstructured":"Johnson MW, Maestranzi S, Duffy AM, et al. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol. 2008;20:174\u2013179.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1494_CR80","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell. 1999;97:889\u2013901.","journal-title":"Cell"},{"key":"1494_CR81","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/carcin\/bgn188","volume":"29","author":"O Turovskaya","year":"2008","unstructured":"Turovskaya O, Foell D, Sinha P, et al. RAGE, carboxylated glycans and S100A8\/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis. 2008;29:2035\u20132043.","journal-title":"Carcinogenesis"},{"key":"1494_CR82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1189\/jlb.0903435","volume":"76","author":"S Ghavami","year":"2004","unstructured":"Ghavami S, Kerkhoff C, Los M, et al. Mechanism of apoptosis induced by S100A8\/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J Leukoc Biol. 2004;76:169\u2013175.","journal-title":"J Leukoc Biol"},{"key":"1494_CR83","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbamcr.2007.10.015","volume":"1783","author":"S Ghavami","year":"2008","unstructured":"Ghavami S, Kerkhoff C, Chazin WJ, et al. S100A8\/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac\/DIABLO and Omi\/HtrA2. Biochim Biophys Acta. 2008;1783:297\u2013311.","journal-title":"Biochim Biophys Acta"},{"key":"1494_CR84","first-page":"4423","volume":"23","author":"Y Nakayama","year":"2003","unstructured":"Nakayama Y, Inoue Y, Minagawa N, et al. Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Res. 2003;23:4423\u20134426.","journal-title":"Anticancer Res"},{"key":"1494_CR85","doi-asserted-by":"crossref","unstructured":"Nagorsen D, Voigt S, Berg E, et al. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med. 2007;5:62.","DOI":"10.1186\/1479-5876-5-62"},{"key":"1494_CR86","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/jnci\/djj498","volume":"98","author":"T Arumugam","year":"2006","unstructured":"Arumugam T, Ramachandran V, Logsdon CD. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006;98:1806\u20131818.","journal-title":"J Natl Cancer Inst"},{"key":"1494_CR87","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","volume":"27","author":"AG R\u00f8seth","year":"1992","unstructured":"R\u00f8seth AG, Fagerhol MK, Aadland E, et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol. 1992;27:793\u2013798.","journal-title":"Scand J Gastroenterol"},{"key":"1494_CR88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00005176-200102000-00015","volume":"32","author":"SK Bunn","year":"2001","unstructured":"Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;32:171\u2013177.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1494_CR89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3748\/wjg.14.53","volume":"14","author":"JY Xiang","year":"2008","unstructured":"Xiang JY, Ouyang Q, Li GD, et al. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis. World J Gastroenterol. 2008;14:53\u201357.","journal-title":"World J Gastroenterol"},{"key":"1494_CR90","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ajg.2008.119","volume":"104","author":"GT Ho","year":"2009","unstructured":"Ho GT, Lee HM, Brydon G, et al. Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis. Am J Gastroenterol. 2009;104:673\u2013678.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1494-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1494-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1494-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T09:54:21Z","timestamp":1559901261000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1494-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,4]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1494-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,4]]}}}